Magnetic therapy for peripheral artery disease gets $7 million
A therapeutics company that has developed a magnetic drug-delivery therapy to treat peripheral artery disease has received a $7 million venture capital investment in a series A financing round. Devon Park Bioventures, a Wayne, Pennsylvania venture capital firm, invests mainly in therapeutics. The investment gives the company two board seats at Vascular Magnetics, a spinoff […]